Clinical and genetic heterogeneity in black patients with homozygous β-thalassemia from the Southeastern United States

J. M. Gonzalez-Redondo, T. A. Stoming, K. D. Lanclos, Y. C. Gu, A. Kutlar, T. Nakatsuji, B. Deng, I. S. Han, V. C. McKie, T. H.J. Huisman

Research output: Contribution to journalArticle

145 Scopus citations

Abstract

The presence of various substitutions and deletions resulting in β-thalassemia was studied in 19 black patients with homozygous β-thalassemia and in numerous relatives; all patients were from Georgia, South Carolina, and Alabama. Methodology included gene mapping, amplification of genomic DNA with Taq polymerase, identification of known nucleotide substitutions or a single nucleotide deletion through hybridization with synthetic oligonucleotides, cloning and sequencing of a β-globin gene, and sequencing of amplified genomic DNA. Of the 38 chromosomes tested, 21 (55%) had the A → G substitution at nt -29, eight (21%) had the C → T substitution at nt -88, three (8%) had the substitution at codon 24, while one each of the following abnormalities were also detected frameshift at codon 6, a C → A mutation at nt 848 of the βIVS-II (new), an A → T mutation at codon 61 (new), a deletion of 1.35 kilobases including the 5' end of β, a (G)γ((A)γδβ)°-thalassemia, and one thalassemia determinant that remained unidentified. The C → A mutation at nt 848 of IVS-II occurred at a position 3 nucleotides 5' to the third exon, adjacent to the invariant Ag dinucleotide of the acceptor sequence. The A → T mutation in codon 61 (AAG → TAG) resulted in the creation of a stop codon and thus in ̄°-thalassemia. The various mutations occurred on chromosomes with different haplotypes; however, chromosomes with a specific mutation but with different haplotypes belonged to one specific framework, which suggested that crossovers were responsible for these different types. Hemoglobin (Hb) F levels wre generally high (55% to 75% with 98.5% in one patient with β°/β°); a few patients with specific haplotypes and an α-thalassemia-2 heterozygosity had a lower Hb F level. The (G)γ in the Hb F was consistently high when the C → T mutation occurred at nt -158 to the Cap site of the (G)γ-globin gene; seven patients with +/+ at this site had an average (G)γ of 73.8%, eight patients with +/- had 64.8%, and one patient with -/- had 34.2%. Variations in hematologic values and in Hb F, (G)γ, and Hb A2 levels of relatives with a β-thalassemia heterozygosity depended to some extent on the types of mutations or deletions and on the haplotypes of the chromosomes with the β-thalassemia determinant.

Original languageEnglish (US)
Pages (from-to)1007-1014
Number of pages8
JournalBlood
Volume72
Issue number3
Publication statusPublished - Jan 1 1988

    Fingerprint

ASJC Scopus subject areas

  • Biochemistry
  • Immunology
  • Hematology
  • Cell Biology

Cite this

Gonzalez-Redondo, J. M., Stoming, T. A., Lanclos, K. D., Gu, Y. C., Kutlar, A., Nakatsuji, T., ... Huisman, T. H. J. (1988). Clinical and genetic heterogeneity in black patients with homozygous β-thalassemia from the Southeastern United States. Blood, 72(3), 1007-1014.